Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008386-13
Application #
6498446
Study Section
Special Emphasis Panel (ZGM1-BRT-5 (01))
Program Officer
Okita, Richard T
Project Start
1990-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
13
Fiscal Year
2002
Total Cost
$154,049
Indirect Cost
Name
Georgetown University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lai, En Yin; Luo, Zaiming; Onozato, Maristela L et al. (2012) Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol 303:F64-74
LaConti, Joseph J; Shivapurkar, Narayan; Preet, Anju et al. (2011) Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One 6:e20687
Nagaoka, So Iha; Hodges, Craig A; Albertini, David F et al. (2011) Oocyte-specific differences in cell-cycle control create an innate susceptibility to meiotic errors. Curr Biol 21:651-7
Gibby, Krissa A; McDonnell, Kevin; Schmidt, Marcel O et al. (2009) A distinct role for secreted fibroblast growth factor-binding proteins in development. Proc Natl Acad Sci U S A 106:8585-90
Chen, Xueguang; Patel, Kinjal; Connors, Stephanie G et al. (2007) Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 293:H3246-53
Knollmann, Bjorn C; Smyth, Brendan J; Garnett, Christine E et al. (2005) Personal digital assistant-based drug reference software as tools to improve rational prescribing: benchmark criteria and performance. Clin Pharmacol Ther 78:7-18
Desai, M; Tanus-Santos, J E; Li, L et al. (2003) Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6. Pharmacogenomics J 3:105-13
Desta, Zeruesenay; Zhao, Xiaojiong; Shin, Jae-Gook et al. (2002) Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet 41:913-58
Rosebraugh, Curtis J; Honig, Peter K; Yasuda, Sally Usdin et al. (2002) Centers for education and research on therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United States. Clin Pharmacol Ther 71:4-10
Rae, James M; Soukhova, Nadia V; Flockhart, David A et al. (2002) Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism. Drug Metab Dispos 30:525-30

Showing the most recent 10 out of 29 publications